# Depression and Cardiovascular Risk Markers: Effects of Rosuvastatin Therapy

> **NCT00951132** · PHASE2 · WITHDRAWN · sponsor: **University Hospital, Akershus**

## Conditions studied

- Depression

## Interventions

- **DRUG:** rosuvastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00951132
- **Lead sponsor:** University Hospital, Akershus
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-09
- **Primary completion:** 2012-12
- **Final completion:** 2013-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Failure to include patients
- **Last updated:** 2023-02-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00951132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00951132, "Depression and Cardiovascular Risk Markers: Effects of Rosuvastatin Therapy". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT00951132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*